IL186307A0 - Human glp-1 mimetibodies, compositions, methods and uses - Google Patents

Human glp-1 mimetibodies, compositions, methods and uses

Info

Publication number
IL186307A0
IL186307A0 IL186307A IL18630707A IL186307A0 IL 186307 A0 IL186307 A0 IL 186307A0 IL 186307 A IL186307 A IL 186307A IL 18630707 A IL18630707 A IL 18630707A IL 186307 A0 IL186307 A0 IL 186307A0
Authority
IL
Israel
Prior art keywords
mimetibodies
compositions
methods
human glp
glp
Prior art date
Application number
IL186307A
Other languages
English (en)
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Publication of IL186307A0 publication Critical patent/IL186307A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL186307A 2005-03-28 2007-09-25 Human glp-1 mimetibodies, compositions, methods and uses IL186307A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2005097175 2005-03-28
PCT/US2005/046884 WO2007081302A2 (fr) 2005-03-28 2005-12-22 Miméticorps de la glp-1 humaine, compositions, procédés et utilisations

Publications (1)

Publication Number Publication Date
IL186307A0 true IL186307A0 (en) 2008-01-20

Family

ID=38256744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186307A IL186307A0 (en) 2005-03-28 2007-09-25 Human glp-1 mimetibodies, compositions, methods and uses

Country Status (12)

Country Link
EP (1) EP1871811A4 (fr)
JP (1) JP2008546373A (fr)
KR (1) KR20080005378A (fr)
CN (1) CN101389346A (fr)
AU (1) AU2005339797A1 (fr)
BR (1) BRPI0520168A2 (fr)
CA (1) CA2603359A1 (fr)
CR (1) CR9481A (fr)
IL (1) IL186307A0 (fr)
MX (1) MX2007011975A (fr)
NO (1) NO20075272L (fr)
WO (1) WO2007081302A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200843794A (en) * 2006-12-21 2008-11-16 Centocor Inc Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
CN111574583B (zh) * 2020-04-10 2021-06-25 上海海路生物技术有限公司 蛋白复性试剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656728B1 (en) * 1999-02-08 2003-12-02 Chiron Corporation Fibroblast growth factor receptor-immunoglobulin fusion
ES2311560T3 (es) * 2000-12-07 2009-02-16 Eli Lilly And Company Proteinas de fusion glp-1.
JP2006504406A (ja) * 2002-06-28 2006-02-09 セントカー・インコーポレーテツド 哺乳動物のｃｈ１欠失ミメティボディ、組成物、方法および使用
EP1575499A2 (fr) * 2002-06-28 2005-09-21 Centocor, Inc. Corps mimetiques d'epo de mammifere a deletion ch1, compositions, methodes et utilisations associees
WO2005005604A2 (fr) * 2003-06-30 2005-01-20 Centocor, Inc. Proteines derivees de l'immunoglobuline anti-cible et genetiquement modifiees, compositions, procedes et utilisations
EA011583B1 (ru) * 2004-03-31 2009-04-28 Сентокор, Инк. Миметические антитела glp-1 человека, композиции, способы и применения

Also Published As

Publication number Publication date
AU2005339797A1 (en) 2007-07-19
MX2007011975A (es) 2008-03-14
NO20075272L (no) 2007-12-28
CR9481A (es) 2009-01-14
CA2603359A1 (fr) 2007-07-19
EP1871811A2 (fr) 2008-01-02
CN101389346A (zh) 2009-03-18
BRPI0520168A2 (pt) 2009-04-22
EP1871811A4 (fr) 2009-07-22
WO2007081302A3 (fr) 2008-11-13
WO2007081302A2 (fr) 2007-07-19
JP2008546373A (ja) 2008-12-25
KR20080005378A (ko) 2008-01-11

Similar Documents

Publication Publication Date Title
ZA200709266B (en) Human GLP-1 mimetibodies, compositions, methods and uses
HUS1800021I1 (hu) Humán anti-Il-23 ellenanyagok, készítmények, eljárások és alkalmazások
ZA200901132B (en) Human GLP-1 mimetibodies, compositions, methods and uses
HK1209729A1 (en) Compounds, compositions and methods
IL209494A (en) Formulations of insulin oligomeric monoconogues and their use
IL183940A0 (en) Glp-1 agonists, compositions, methods and uses
IL191655A0 (en) Novel compounds, their preparation and use
EP1895838A4 (fr) Preparations et methodes
IL191072A0 (en) Therapeutic compositions and methods
GB0601143D0 (en) Uses, methods and compositions
EP1962852A4 (fr) Composes, compositions et methodes
IL190781A0 (en) Glp-2 mimetibodies, polypeptides, compositions, methods and uses
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
ZA200804502B (en) GLP-2 mimetibodies, polypeptides, compositions, methods and uses
IL177759A0 (en) Cospeptin, cosmedin and their uses
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
GB0501348D0 (en) Compositions and methods
IL186307A0 (en) Human glp-1 mimetibodies, compositions, methods and uses
GB0506496D0 (en) Compound, composition and use
ZA200608999B (en) Human GLP-1 mimetibodies, compositions, methods and uses
GB2444005B (en) Compound, composition and use
GB0505203D0 (en) Skin composition treatment
GB0517546D0 (en) Therapeutic methods and compositions
GB0506495D0 (en) Compound, composition and use
GB0520690D0 (en) Compound, composition and use